Nuveen Minnesota Quality Municipal Income FundNMS
NMS
0
Funds holding %
of 7,419 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
20% more capital invested
Capital invested by funds: $5.12M [Q3] → $6.16M (+$1.03M) [Q4]
20% more funds holding
Funds holding: 15 [Q3] → 18 (+3) [Q4]
1.75% more ownership
Funds ownership: 6.85% [Q3] → 8.6% (+1.75%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for NMS.
Financial journalist opinion
Neutral
Seeking Alpha
2 weeks ago
NMS: Nuveen's Minnesota Municipal Bond CEF Rates A Sell, Here's An Alternative
A well-run single-state municipal bond fund benefits investors who pay taxes to that state. Here I examine Nuveen Minnesota Quality Municipal Income Fund directed at Minnesota taxpayers. Along with my analysis of NMS, its performance relative to a national municipal bond CEF is provided to help judge the worthiness of state funds over a national fund. With the goal to provide higher cash flows and support secondary market trading, Nuveen increased payouts on many funds to close discounts and enhance shareholder returns.
Neutral
Business Wire
10 months ago
Nuveen Closed-End Funds Declare Distributions
NEW YORK--(BUSINESS WIRE)--Several Nuveen closed-end funds have declared distributions. These funds represent investment strategies for investors seeking diversified sources of cash flow to prepare for and sustain their retirement income needs. For further information regarding fund distributions, including earnings, undistributed net investment income, and notices, please visit www.nuveen.com/cef. Additionally, several funds have announced distribution increases of up to 71%. The distribution.
Neutral
Business Wire
10 months ago
Otsuka and Lundbeck Present Results from Three Clinical Trials of Brexpiprazole in Combination with Sertraline for the Treatment of Post-Traumatic Stress Disorder (PTSD) in Adults
PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) today presented results from the Phase II (Trial 061) and Phase III trials (Trial 071 and 072) evaluating the safety and efficacy of brexpiprazole in combination with sertraline for the treatment of adults with post-traumatic stress disorder (PTSD).1,2 The findings were presented at the American Society of Clinical Psychopharmac.
Neutral
Business Wire
1 year ago
Nuveen Closed-End Funds Declare Distributions and Updates to Distribution Policies
NEW YORK--(BUSINESS WIRE)--Nuveen Closed-End Funds today announced that the Board of Trustees of the Funds has approved the regular monthly and quarterly distributions. In addition, the Board of Trustees has approved updated distribution polices described below under “Monthly & Quarterly Distributions” for The Nuveen Preferred & Income Opportunities Fund (NYSE: JPC), Nuveen Preferred and Income Term Fund (NYSE: JPI), Nuveen Variable Rate Preferred & Income Fund (NYSE: NPFD), Nuveen.
Charts implemented using Lightweight Charts™